Anzeige
Mehr »
Samstag, 09.08.2025 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3E2MX | ISIN: US70387R4039 | Ticker-Symbol: 1P50
Lang & Schwarz
09.08.25 | 09:00
1,000 Euro
-100,00 % -1,000
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
PAVMED INC Chart 1 Jahr
5-Tage-Chart
PAVMED INC 5-Tage-Chart
RealtimeGeldBriefZeit
1,0001,00009:00

Aktuelle News zur PAVMED Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
30.07.PAVmed granted 180-day extension to meet Nasdaq minimum bid price1
30.07.PAVmed Inc. - 8-K, Current Report1
30.07.PAVmed Inc.: PAVmed Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule72NEW YORK, July 30, 2025 /PRNewswire/ -- PAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating...
► Artikel lesen
28.07.PAVmed Inc. - S-8, Securities to be offered to employees in employee benefit plans1
18.06.PAVmed Inc. - 8-K, Current Report1
15.05.PAVmed Q1 2025 slides: net income soars amid strategic restructuring2
15.05.PAVmed Inc. - 8-K, Current Report1
15.05.PAVmed Non-GAAP EPS of -$0.07 beats by $0.22, revenue of $0.08M beats by $0.07M1
PAVMED Aktie jetzt für 0€ handeln
15.05.PAVmed Inc.: PAVmed Provides Business Update and Reports First Quarter 2025 Financial Results108Lucid secured capital to extend runway well past key upcoming reimbursement milestones; ended 1Q25 with over $40 million in proforma cash Veris Health completed...
► Artikel lesen
15.05.PAVmed Non-GAAP EPS of -$0.16 beats by $0.13, revenue of $0.83M beats by $0.82M1
14.05.PAVmed's Earnings: A Preview2
30.04.NSE - PAVmed Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities1
25.04.PAVmed Inc. - 8-K, Current Report-
11.04.PAVmed Inc. - 8-K, Current Report1
25.03.PAVmed outlines strategic milestones for 2025, including Veris implantable device submission1
25.03.PAVmed Inc.: PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results221Lucid processed record test volume, saw rapid initial uptake in concierge medicine contracts, and secured first commercial insurance coverage policies Veris Health...
► Artikel lesen
25.03.PAVmed Inc. - 8-K, Current Report-
25.03.PAVmed Non-GAAP EPS of -$0.06 beats by $0.34, revenue of $0.01M misses by $0.01M2
24.03.PAVmed Inc. - 10-K, Annual Report1
21.03.PAVmed Q4 2024 Earnings Preview2
Weiter >>
26 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1